Variants of Concern Are Overrepresented Among Postvaccination Breakthrough Infections of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Washington State
Clicks: 194
ID: 273685
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
194 views
20 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #194 of 1,084 articles by views in clinical infectious diseases
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract. Across 20 vaccine breakthrough cases detected at our institution, all 20 (100%) infections were due to variants of concern (VOCs) and had a median Ct
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (23 words).
Try re-searching for a better abstract.
| Reference Key |
eclinicalvariants
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | McEwen, Abbye E;Cohen, Seth;Bryson-Cahn, Chloe;Liu, Catherine;Pergam, Steven A;Lynch, John;Schippers, Adrienne;Strand, Kathy;Whimbey, Estella;Mani, Nandita S;Zelikoff, Allison J;Makarewicz, Vanessa A;Brown, Elizabeth R;Bakhash, Shah A Mohamed;Baker, Noah R;Castor, Jared;Livingston, Robert J;Huang, Meei-Li;Jerome, Keith R;Greninger, Alexander L;Roychoudhury, Pavitra; |
| Journal | clinical infectious diseases |
| Year | Year not found |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.